True North is a biotechnology company that engages in research and development of humanized antibodies and novel therapies to treat rare diseases... Read more
True North is a biotechnology company that engages in research and development of humanized antibodies and novel therapies to treat rare diseases... Read more
News
May 31, 2017
BioPortfolio
True North Therapeutics: Abzenas partner True North Therapeutics subject of US$825m takeover
May 24, 2017
Proactive Investors
True North Therapeutics: Bioverativ buys blood disorder peer True North Therapeutics for US$400mln
May 24, 2017
Global Corporate Venturing
True North Therapeutics: True North heads to Bioverativ in $400m acquisition
May 24, 2017
Center Watch
True North Therapeutics: Bioverativ to acquire True North Therapeutics
May 23, 2017
FE Investegate
True North Therapeutics: Abzena PLC : Abzena notes True North Therapeutics acquisition
Apr 05, 2017
BioPortfolio
True North Therapeutics: True North Expands Leadership Team to Advance Pipeline of Novel Rare Disease Treatments Targeting the Complement System
Feb 20, 2017
PMLiVE
True North Therapeutics: BioMarin's chief commercial officer joins True North's board
Feb 06, 2017
Blackbird
Press Release: True North Therapeutics : Bullous Pemphigoid - Pipeline Review, H2 2016 - Key Vendors are iCo Therapeutics Inc, Immungenetics AG, True North Therapeutics & TxCell SA - Research and Markets
Feb 01, 2017
BioPortfolio
True North Therapeutics: True North Appoints Biotechnology Commercial Executive Jeff Ajer to its Board of Directors
Jan 09, 2017
PharmiWeb
True North Therapeutics: True North Provides Corporate Update at J.P. Morgan Healthcare Conference
True North Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10